Jeannette Vasquez-Vivar

Jeannette Vasquez-Vivar

Auto-generated profile, based on publicly available information

Jeannette Vasquez-Vivar

Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JVJeannette Vásquez-Vivar
Jeannette Vásquez-Vivar
BKB. Kalyanaraman
B. Kalyanaraman
MKMary Claire Kennedy
Mary Claire Kennedy
Mitochondrial aconitase (m-aconitase) contains a [4Fe-4S]2+ cluster in its active site that catalyzes the stereospecific dehydration-rehydration of citrate to isocitrate in the Krebs cycle. It has been proposed that the [4Fe-4S]2+ aconitase is oxidized by superoxide, generating the inactive [3Fe-4S]1+ aconitase. In this reaction, the likely products are iron(II) and hydrogen peroxide. Consequently, the inactivation of m-aconitase by superoxide may increase the formation of hydroxyl radical (⋅OH) through the Fenton reaction in mitochondria. In this work, evidence for the generation of ⋅OH from the reaction of m-aconitase with superoxide is provided using ESR spin trapping experiments with 5-diethoxyphosphoryl-5-methyl-1-pyrroline N-oxide and α-phenyl-N-tert-butylnitrone. Formation of free ⋅OH was verified with the ⋅OH scavenger Me2SO, which forms methyl radical upon reacting with⋅OH. The addition of Me2SO to incubation mixtures containing m-aconitase and xanthine/xanthine oxidase yielded methyl radical, which was detected by ESR spin trapping. Methyl radical formation was further confirmed using [13C]Me2SO. Parallel low temperature ESR experiments demonstrated that the generation of the [3Fe-4S]1+ cluster increased with increasing additions of superoxide to m-aconitase. This reaction was reversible, as >90% of the initial aconitase activity was recovered upon treatment with glutathione and iron(II). This mechanism presents a scenario in which⋅OH may be continuously generated in the mitochondria.

1 January 2003 in Free Radical Research
Verified
Journal Article
Closed access
JVJeannette Vásquez-Vivar
Jeannette Vásquez-Vivar
BKB. Kalyanaraman
B. Kalyanaraman
PMPavel Martásek
Pavel Martásek
Tetrahydrobiopterin (BH4) is a ubiquitous pteridine metabolite that serves as a NOS cofactor. Recently, we showed that BH4 efficiently inhibits superoxide generation from the heme group at the oxygenase domain of eNOS. This role indicates that BH4 acts as a redox switch in the catalytic mechanism of the enzyme, which may have important consequences in the physiology of the endothelium. Here the mechanism by which BH4 inhibits superoxide release from eNOS and the "uncoupling" effects of oxidized BH4 metabolites are presented. The implications of the disparate actions of fully reduced and oxidized BH 4 metabolites in the control of eNOS biochemistry are discussed in the light of clinical data indicating that BH 4 levels are important in the regulation of superoxide levels and of endothelial reactivity.

15 March 2002 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
JVJeannette Vásquez-Vivar
Jeannette Vásquez-Vivar
PMPavel Martásek
Pavel Martásek
JWJennifer Whitsett
Jennifer Whitsett
JJJoy Joseph
Joy Joseph
BKBalaraman Kalyanaraman
Balaraman Kalyanaraman
Augmentation of superoxide levels has been linked to impaired relaxation in hypertension, diabetes and hypercholesterolaemia. Purified endothelial nitric oxide synthase (eNOS) generates superoxide under limited availability of 5,6,7,8-tetrahydrobiopterin (BH4). Thus alterations in endothelial BH4 levels have been postulated to stimulate superoxide production from eNOS. This possibility was examined by determining the concentration-dependent effects of BH4, and its analogues, on superoxide formation by eNOS. Superoxide was quantified by EPR spin trapping, which is the only available technique to quantify superoxide from eNOS. Using 5-ethoxycarbonyl-5-methyl-pyrroline N-oxide, we show that only fully reduced BH4 diminished superoxide release from eNOS, with efficiency BH4>6-methyl-BH4>5-methyl-BH4. In contrast, partially oxidized BH4 analogues, 7,8-dihydrobiopterin (7,8-BH2) and sepiapterin had no effect. Neither l-arginine nor NG-nitro-l-arginine methyl ester (l-NAME) abolished superoxide formation. Together, BH4 and l-arginine stimulated ˙NO production at maximal rates of 148nmol/min per mg of protein. These results indicate that BH4 acts as a ‘redox switch’, decreasing superoxide release and enhancing ˙NO formation. This role was verified by adding 7,8-BH2 or sepiapterin to fully active eNOS. Both 7,8-BH2 and sepiapterin enhanced superoxide release while inhibiting ˙NO formation. Collectively, these results indicate that the ratio between oxidized and reduced BH4 metabolites tightly regulates superoxide formation from eNOS. The pathological significance of this scenario is discussed.

1 October 2001 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JVJeannette Vásquez-Vivar
Jeannette Vásquez-Vivar
JWJennifer Whitsett
Jennifer Whitsett
PMPavel Martásek
Pavel Martásek
NHNeil Hogg
Neil Hogg
BKB. Kalyanaraman
B. Kalyanaraman

1 October 2009 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JVJeannette Vásquez-Vivar
Jeannette Vásquez-Vivar

30 November 2024 in Redox Biology
Verified
Journal Article
Open access
RTR. Steven Traeger
R. Steven Traeger
JWJames Woodcock
James Woodcock
STSidhartha Tan
Sidhartha Tan
ZSZhongjie Shi
Zhongjie Shi
JVJeannette Vasquez-Vivar
Jeannette Vasquez-Vivar
Tetrahydrobiopterin (BH4) deficiency is caused by genetic abnormalities that impair its biosynthesis and recycling, which trigger neurochemical, metabolic, and redox imbalances. Low BH4 levels are also associated with hypoxia, reperfusion reoxygenation, endothelial dysfunction, and other conditions that are not genetically determined. The exact cause of changes in BH4 in nongenetic disorders is not entirely understood, but a role for oxidant species has been implicated. The oxidation of BH4 generates several products, including 7,8-dihydrobiopterin (BH2), the accumulation of which is predicted in cells with low dihydrofolate reductase activity. The relative efficiency of oxidant species at causing variations in BH4/BH2 levels in cells furnished with several antioxidant enzymes has not yet been systematically analyzed. This study examined the quantitative changes of BH4/BH2 in cells challenged with several oxidants. We showed that BH2 is not a major product of treatments with hydrogen peroxide or RSL3, as indicated by the moderate effect of dihydrofolate reductase-inhibitor methotrexate on the accumulation of BH2. However, we found a net loss in BH4/BH2, suggesting that products other than BH2 were generated. These reactions were further examined in NOX4-expressing HEK cells producing hydrogen peroxide. These cells showed slightly decreased BH4/BH2 ratios compared with HEK wild-type cells, and, again, methotrexate treatment moderately increased BH2 levels. In contrast, peroxynitrite-producing RAW 264.7 cells showed dramatically decreased BH4 levels without BH2 accumulation. Following the activation of peroxynitrite production with PMA in lipopolysaccharide-treated cells, we also found a significant time-dependent decline in GTPCH-I protein levels. We conclude that hydrogen peroxide is the least effective oxidant species at decreasing intracellular BH4 levels, while peroxynitrite is highly effective by targeting GTPCH-I and BH4 directly. Moreover, we conclude that BH4/BH2 levels are not a determinant of RSL3 cytotoxicity.